Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.
- NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_assertion description "[Despite the high incidence of revertant mosaicism (35%) in patients with the genetic skin disease epidermolysis bullosa (EB) due to correcting mutations in the genes COL17A1 and LAMB3, revertant mosaicism has not been described for COL7A1 until recently.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.
- NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_assertion evidence source_evidence_literature NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.
- NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_assertion SIO_000772 20574443 NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.
- NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_assertion wasDerivedFrom befree-20150227 NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.
- NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_assertion wasGeneratedBy ECO_0000203 NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP320473.RA2G_FB69je_xwUBwinyIiLlGOBufgh9DgtTjMqRg_pH0130_provenance.